Effect of Metformin and Rosiglitazone Over no Diabetic With Metabolic Syndrome Patients.
Condition: Insulin Resistance Interventions: Drug: Metformin group; Drug: Rosiglitazone group; Drug: Placebo oral tablet Sponsors: J JESUS VENEGAS, MD; Instituto Mexicano del Seguro Social; National Council of Science and Technology, Mexico Completed
Source: ClinicalTrials.gov - Category: Research Source Type: clinical trials
More News: Avandia | Diabetes | Endocrinology | Fortamet | Metabolic Syndrome | Metformin | Mexico Health | Research | Science